
Vivanza Biosciences Reschedules Board Meeting to Aug 7
Vivanza Biosciences Ltd has revised its Board Meeting date from August 1st, 2026, to August 7th, 2026. The meeting will be held at the company's registered office to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. Other agenda items include taking note of disclosures of interest and declarations from independent directors. The trading window for designated persons remains closed until 48 hours after the declaration of financial results.
Key Highlights
- Board meeting rescheduled from August 1st to August 7th, 2026.
- Agenda includes approval of Q1 FY27 Unaudited Financial Results.
- Limited Review Report for financial results will be considered.
- Trading window remains closed for designated personnel.
Price Impact
More from VIVANZA
Vivanza Biosciences Board Meeting on Aug 1 to Approve Q1 FY27 Results
Vivanza Biosciences: Auditor Issues Unmodified Opinion on Audited Financials
Vivanza Biosciences Board Approves Share Transfer and Appoints Company Secretary